Peptide Schedule
Glandokort6 residuesAEDPVGEach bubble = one amino acid. Size = residue mass. Color = chemical class.Glandokort
Benefits
About Glandokort
Glandokort is a peptide bioregulator derived from the adrenal glands of young animals through acid extraction and purification. The active component, peptide complex A-17, contains low-molecular-weight peptides (under 5,000 Da) that are proposed to interact selectively with adrenal cortex cells to normalize their metabolic activity. A clinical study enrolled 36 patients (ages 37-62) with chronic adrenal cortex insufficiency and prolonged stress exposure. Patients received 1 capsule twice daily for 30 days alongside standard adaptogen therapy. The study reported improvements in physical and mental performance, mood, and sleep quality compared to controls. Researchers also observed restoration of metabolic activity in the reticular adrenal zone, with increased production of aldosterone and 17-ketosteroids returning to normal-range values. This single clinical study wasn't published in an indexed peer-reviewed journal, and the evidence base remains thin by Western standards. No randomized, double-blind, placebo-controlled trials have been conducted.
Who Should Consider Glandokort
- Individuals with chronic adrenal cortex insufficiency
- People experiencing prolonged occupational or psycho-emotional stress
- Adults with HPA axis dysfunction
- Those seeking non-invasive adrenal support through oral peptide bioregulation
How Glandokort Works
Glandokort follows the Khavinson bioregulator model: short-chain peptides cross cell membranes and enter the nucleus, where they bind specific DNA sequences on promoter segments of genes involved in adrenal steroidogenesis. This interaction upregulates expression of enzymes in the cortisol, aldosterone, and androgen biosynthetic pathways. The clinical observation of increased aldosterone and 17-ketosteroid production suggests effects on CYP11B2 and DHEA-related pathways, though this hasn't been confirmed at the molecular level. Glandokort is also reported to possess antioxidant properties, reducing lipid peroxidation in adrenal tissue.
What to Expect
No significant changes expected. The peptide complex begins interacting with adrenal tissue.
Some users report subtle improvements in energy levels, stress tolerance, and mood stability based on anecdotal reports.
The clinical study observed improvements in performance, mood, and sleep quality by the end of a 30-day course. Hormonal markers showed normalization.
Effects are proposed to persist after the course ends due to ongoing gene expression changes in adrenal tissue.
Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 10mg | Daily |
| Moderate | 10mg | 2x Daily |
| Aggressive | 20mg | 2x Daily |
Note: Glandokort is an oral peptide bioregulator containing complex A-17, a mixture of short-chain peptides extracted from the adrenal glands of young cattle or pigs. Each capsule contains approximately 10 mg of active peptides. Standard protocols use 1-2 capsules twice daily for 10-30 days, repeated 2-3 times per year.
How to Inject Glandokort
Take 1-2 capsules twice daily with meals, swallowed whole with water. Morning and early afternoon dosing is preferred to align with the natural circadian rhythm of cortisol production. Standard course length is 10-30 days, repeated every 3-6 months.
Cycling Protocol
Standard Russian protocol: 1-2 capsules twice daily with meals for 10-30 days, repeated 2-3 times per year.
Pharmacokinetics
Source: Estimated from general short peptide pharmacokinetics; no Glandokort-specific PK studies published
Loading the interactive decay curve.
Side Effects
Glandokort hasn't been associated with serious adverse events in the limited clinical data available. The 2011 St. Petersburg study reported no side effects during 30 days of administration. Theoretical risks include allergic reactions to animal-derived proteins and gastrointestinal discomfort.
Contraindications
- Pregnancy and breastfeeding (no safety data available)
- Known hypersensitivity to animal-derived peptide preparations
- Active adrenal tumors or Cushing's syndrome
- Children under 18 (insufficient safety data)
Drug Interactions
- Use caution with corticosteroid medications — additive effects on adrenal hormone levels are theoretically possible
- May interact with mineralocorticoid receptor antagonists (spironolactone, eplerenone)
- No formal drug interaction studies have been conducted
Storage & Stability
Molecular Profile
Related Peptides
References
- Peptide Regulation of Gene Expression: A Systematic ReviewPubMed 34834147
- Short Peptides Regulate Gene ExpressionPubMed 27909961
- Peptide bioregulators: the new class of geroprotectors. Clinical studies resultsPubMed 24003726
- Peptide bioregulators: the new class of geroprotectors. Experimental studiesPubMed 23734519
- Peptide regulation of aging: 35-year research experiencePubMed 19902107